Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Chao Yan Co., Ltd. in the medical device industry, noting its high PE ratio compared to industry averages [1][2] - As of July 31, Chao Yan Co., Ltd. closed at 26.75 yuan, with a rolling PE ratio of 72.39 times and a total market capitalization of 11.458 billion yuan [1] - The average PE ratio for the medical device industry is 54.89 times, with a median of 37.06 times, placing Chao Yan Co., Ltd. at the 94th position in the industry ranking [1][2] Group 2 - As of March 31, 2025, Chao Yan Co., Ltd. had 26,755 shareholders, a decrease of 23,411 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of Chao Yan Co., Ltd. includes the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products being industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] Group 3 - In the latest quarterly report for Q1 2025, Chao Yan Co., Ltd. achieved a revenue of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1] - The company received the second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" in 2022 [1]
超研股份收盘下跌1.73%，滚动市盈率72.39倍，总市值114.58亿元